Leadless Pacemakers Market To Reach $1,622.87 Million By 2033

November 2025 | Report Format: Electronic (PDF)

Leadless Pacemakers Market Growth & Trendss

The global leadless pacemakers market size is anticipated to reach USD 1,622.87 million by 2033, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 6.48% from 2025 to 2033. This growth is attributed to technological advancements, rising prevalence of heart diseases, and a preference for minimally invasive procedures. Moreover, the growing aging population globally propels the demand for leadless pacemakers, as bradycardia is common in the geriatric population. According to the Cleveland Clinic, approximately half a million of the geriatric population show the symptoms of bradycardia, thereby driving the industry.

Wireless or leadless pacemakers, frequently used in adult patients, have emerged as a potentially safe and efficient temporary alternative for children experiencing bradycardia, as revealed by research featured in Circulation: Arrhythmia and Electrophysiology, a peer-reviewed journal affiliated with the American Heart Association. This development is expected to be a potential driver for the market growth.

In addition, growing business initiatives by companies for leadless pacemakers propel the industry's growth. For instance, in January 2024, Medtronic plc announced it had received the CE (Conformite Europeenne) Mark for its Micra AV2 and Micra VR2, leadless pacemakers. The Micra AV2 and Micra VR2, which are recognized as the smallest pacemakers globally, offer extended battery life and simplified programming in comparison to earlier models of Micra pacemakers. Despite these advancements, they retain the numerous advantages of leadless pacing, including a reduction in complications when compared to traditional pacemakers.

key Request a free sample copy or view report summary: Leadless Pacemakers Market Report

Leadless Pacemakers Market Report Highlights

Based on the pacing chamber, single chamber accounted for the largest revenue market share of 54.54% in 2024 due to the suitability for a broader range of patients with bradycardia or heart block
Based on the pacing chamber, the dual chamber segment is estimated to be the fastest growing during the forecast period owing to their ability to address a broader range of cardiac conditions
The inpatient facilities segment dominated the market with a revenue share of 88.8% in 2024 and the outpatient facilities segment is expected to be the fastest growing, with a CAGR of 14.3% during the forecast period
In 2024, North America dominated with a share of 60.4% due to technological advancements, increasing heart diseases, and accessibility and availability of skilled professionals. Asia Pacific is expected to grow at the fastest CAGR of 15.1% during the forecast period the growing collaborations, increasing health expenditure, government initiatives, increasing CVD, and geographic expansion